|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net Loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities | |||||
| Depreciation | |||||
| Amortization of right-of-use assets | |||||
| Bad debts written off | |||||
| Amortization of intangible assets | |||||
| Impairment of goodwill | |||||
| Loss on disposal of subsidiary | |||||
| Impairment loss of other receivable | |||||
| Inventory written-down | |||||
| Written-off of accrual legal fee | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivables | |||||
| Prepayments, deposits and other receivables | |||||
| Inventories | |||||
| Accounts payables | |||||
| Advance received | |||||
| Contract liabilities | |||||
| Accrued liabilities, deposit received and other payables | |||||
| Operating lease liabilities | |||||
| Net cash provided by/(used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITY: | |||||
| Purchase of property, plant and equipment | |||||
| Disposal of subsidiary, net of cash disposed | |||||
| Net cash used in investing activity | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from share issuance | |||||
| Advance to related parties | |||||
| Advances from directors | |||||
| Total advances from directors | |||||
| Net cash (used in)/provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | |||||
| Supplemental disclosures of cash flow information: | |||||
| Income tax paid (refund) | |||||
Loading...